Sarcoma / 2019 / Article / Tab 1

Research Article

Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

Table 1

Demographic and clinical characteristics of uterine LMS patients stratified by receipt of chemotherapy.

CharacteristicsChemotherapy No chemotherapy
Number%Number%

Age at diagnosis, y<0.0001
18–39667.11076.0
40–4927028.846726.0
50–6447550.779444.2
65+12513.442823.8

Race (missing from analysis: )0.7531
White70179.7132778.4
African American17920.336521.6

Hispanic (missing from analysis: )0.0292
Yes798.81116.5
No81491.2159693.5

Comorbidities (Charlson/Deyo score)0.1509
078784.1146081.3
112613.527515.3
2232.5613.4

Insurance status (missing from analysis: )<0.0001
Medicare12213.244224.9
Private65771.0111262.8
Medicaid/Other government899.61206.8
None576.2985.5

Median household income ($) (missing from analysis: )0.4726
<38,00016417.732918.6
38,000–47,99919821.436620.7
48,000–62,99925227.244124.9
>63,00031133.663435.8

Education (% no high school diploma) (missing from analysis: )0.0355
≥2116617.932118.1
13–20.918520.043724.7
7–12.933536.257632.5
<723925.843624.6

Location of patient (missing from analysis: )0.0902
Large metropolitan57462.7101358.7
Small metropolitan23625.848428.0
Suburban758.21458.4
Rural303.3854.9

Hospital volume (cases per year)0.0181
0.09384.1995.5
0.18–0.2710311.025614.3
0.36–0.5518119.335319.7
0.64–7.2761465.6108860.6

Regional lymph nodes positive (missing from analysis: )<0.0001
Yes308.0132.0
No34792.064298.0

Stage<0.0001
167672.2154185.8
2646.81166.5
319620.91397.7

Year of diagnosis<0.0001
2004–200934536.9100556.0
2010–201459163.179144.0

Radiation (missing from analysis: )0.0406
Yes22524.337320.9
No70075.7141379.1

Oophorectomy (missing from analysis: )0.6492
Yes71684.0143784.7
No13616.025915.3